HIV-1 tat trans-activation requires the loop sequence within tar

Human immunodeficiency virus (HIV-1) is the primary retroviral agent responsible for AIDS and related disorders worldwide. One of its identified gene products, tat protein, stimulates in trans the expression of all HIV-1 genes by several orders of magnitude1–7. Cells infected with HIV-1 require tat protein to produce virus, suggesting that trans-activation is crucial for viral replication8,9. The essential cis-acting site for trans-activation, termed tar, resides within the R region of the HIV-1 long terminal repeat (LTR), between −17 and +54 with respect to the initiation site of viral transcription10,11. It is striking that the RNA encoded between +1 and +59 has the potential to form an extensive stem-loop secondary structure which, as a portion of the untranslated leader RNA, would be common to all HIV-1 mRNAs 11,12. We now present the results of nucleotide substitution experiments which suggest that tat trans-activation requires presentation of the sequence +30CUGGG+34 in tar within the loop of a RNA hairpin structure.

[1]  D. Capon,et al.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein , 1987, Cell.

[2]  M. Feinberg,et al.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA , 1986, Cell.

[3]  M. Emerman,et al.  Genome organization and transactivation of the human immunodeficiency virus type 2 , 1987, Nature.

[4]  J. Sodroski,et al.  Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. , 1985, Science.

[5]  J. Sodroski,et al.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat , 1985, Cell.

[6]  S. Arya,et al.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[7]  D. Baltimore,et al.  The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. , 1987, The EMBO journal.

[8]  J. Sodroski,et al.  Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III , 1986, Nature.

[9]  B. Cullen,et al.  Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Luciw,et al.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product , 1987, Nature.

[11]  J. Sodroski,et al.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication , 1986, Cell.

[12]  M. Gonda,et al.  The trans-activator gene of HTLV-III is essential for virus replication , 1986, Nature.

[13]  P. Luciw,et al.  Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Sodroski,et al.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. , 1985, Science.

[15]  L. Jagodzinski,et al.  New human and simian HIV-related retroviruses possess functional transactivator (tat) gene , 1987, Nature.

[16]  Bryan R. Cullen,et al.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism , 1986, Cell.

[17]  Takashi Okamoto,et al.  Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system , 1986, Cell.

[18]  Michael B. Mathews,et al.  Transcriptional but not translational regulation of HIV-1 by the tat gene product , 1988, Nature.